Skip to content
healthcare.dev

Eslicarbazepine Acetate

NDC 60505-4661, Eslicarbazepine Acetate, tablet, from Apotex Corp..

Product NDC
60505-4661
Status
Listed
Labeler
Apotex Corp.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211236
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4661 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ESLICARBAZEPINE ACETATE800 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]

Package NDCNDC-11Package
60505-4661-36050546610330 TABLET in 1 BOTTLE (60505-4661-3)
60505-4661-96050546610990 TABLET in 1 BOTTLE (60505-4661-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/22f29752-614f-caaf-b595-9deae8a3e3ff
  • NADAC price for package 60505466103

    GET /v1/drugs/nadac/60505466103

Use it

Look up 60505-4661 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60505-4661 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60505-4661. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.